Molecular radiotherapy using cleavable radioimmunoconjugates that target EGFR and γH2AX.
about
Imaging the DNA damage response with PET and SPECTSynthesis and characterization of Her2-NLP peptide conjugates targeting circulating breast cancer cells: cellular uptake and localization by fluorescent microscopic imaging.Improving external beam radiotherapy by combination with internal irradiationDNA double-strand break repair: a theoretical framework and its application.The quest to exploit the Auger effect in cancer radiotherapy - a reflective review.PET imaging of DNA damage using (89)Zr-labelled anti-γH2AX-TAT immunoconjugates.Subcellular Targeting of Theranostic Radionuclides
P2860
Q33581909-C8648C92-5CB0-4D44-9D1D-0B53474D8EFBQ35548992-8D7D5766-2CD6-47FB-9850-6500487AF245Q36235732-38C89A18-BEB8-4642-95D4-8EF13C05D849Q36596145-94C4A0EC-E440-4BD9-8ADC-920E38E2CD0BQ38754712-ACC0543E-58A5-4F73-AFE3-065E9D688E0DQ38868860-D7B7D2D8-23CA-417C-98E6-9372D0DF6A21Q58764832-D9401065-1789-4E6E-B51A-89E29754D84E
P2860
Molecular radiotherapy using cleavable radioimmunoconjugates that target EGFR and γH2AX.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Molecular radiotherapy using cleavable radioimmunoconjugates that target EGFR and γH2AX.
@en
Molecular radiotherapy using cleavable radioimmunoconjugates that target EGFR and γH2AX.
@nl
type
label
Molecular radiotherapy using cleavable radioimmunoconjugates that target EGFR and γH2AX.
@en
Molecular radiotherapy using cleavable radioimmunoconjugates that target EGFR and γH2AX.
@nl
prefLabel
Molecular radiotherapy using cleavable radioimmunoconjugates that target EGFR and γH2AX.
@en
Molecular radiotherapy using cleavable radioimmunoconjugates that target EGFR and γH2AX.
@nl
P2093
P1476
Molecular radiotherapy using cleavable radioimmunoconjugates that target EGFR and γH2AX.
@en
P2093
Andrew Waller
Bart Cornelissen
Katherine A Vallis
Sarah Able
P304
P356
10.1158/1535-7163.MCT-13-0369
P577
2013-08-20T00:00:00Z